92 related articles for article (PubMed ID: 8383089)
1. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content.
Ohiwa T; Katagiri K; Hoshino M; Hayakawa T; Nakai T
Hepatology; 1993 Mar; 17(3):470-6. PubMed ID: 8383089
[TBL] [Abstract][Full Text] [Related]
2. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.
Kitani K; Kanai S; Sato Y; Ohta M
Hepatology; 1994 Apr; 19(4):1007-12. PubMed ID: 8138240
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of chenodeoxycholic acid to beta-muricholic acid in rat liver.
Botham KM; Boyd GS
Eur J Biochem; 1983 Jul; 134(1):191-6. PubMed ID: 6861760
[TBL] [Abstract][Full Text] [Related]
4. A radioimmunoassay for tauro-beta-muricholic acid suitable for use with isolated rat liver cells.
Botham KM; Boyd GS; Williamson D; Beckett GJ
FEBS Lett; 1983 Jan; 151(1):19-21. PubMed ID: 6825837
[TBL] [Abstract][Full Text] [Related]
5. Taurochenodeoxycholic acid induced biphasic hepatotoxicity in isolated perfused rat liver: roles of Ca2+ and calpain.
Hasegawa C; Yamada T; Ohara H; Nakazawa T; Sano H; Ando H; Kunimatsu M; Ozaki Y; Takahashi S; Nomura T; Joh T; Itoh M
Hepatogastroenterology; 2003; 50(52):972-8. PubMed ID: 12845961
[TBL] [Abstract][Full Text] [Related]
6. Tauro beta-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.
Kanai S; Ohta M; Kitani K; Sato Y
Life Sci; 1990; 47(26):2421-8. PubMed ID: 2263167
[TBL] [Abstract][Full Text] [Related]
7. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin reduces taurochenodeoxycholate-induced hepatotoxicity by lowering the hepatocyte taurochenodeoxycholate content.
Nakazawa T; Hoshino M; Hayakawa T; Tanaka A; Ohiwa T
J Hepatol; 1996 Nov; 25(5):739-47. PubMed ID: 8938554
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of hydrophilic bile acids on bile acid hepatotoxicity in the rat.
Kitani K
Ital J Gastroenterol; 1995 Sep; 27(7):366-71. PubMed ID: 8563008
[TBL] [Abstract][Full Text] [Related]
10. Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats.
Takikawa H; Sano N; Aiso M; Takamori Y; Yamanaka M
J Gastroenterol Hepatol; 1997 Jan; 12(1):84-6. PubMed ID: 9076630
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
12. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat.
Roda A; Piazza F; Baraldini M; Speroni E; Guerra MC; Cerré C; Cantelli Forti G
Hepatology; 1998 Feb; 27(2):520-5. PubMed ID: 9462652
[TBL] [Abstract][Full Text] [Related]
13. Effects of dibutyryl cyclic AMP and papaverine on intrahepatocytic bile acid transport. Role of vesicle transport.
Hoshino M; Ohiwa T; Hayakawa T; Kamiya Y; Tanaka A; Hirano A; Kumai T; Katagiri K; Miyaji M; Takeuchi T
Scand J Gastroenterol; 1993 Sep; 28(9):833-8. PubMed ID: 8235441
[TBL] [Abstract][Full Text] [Related]
14. Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential.
Denk GU; Kleiss CP; Wimmer R; Vennegeerts T; Reiter FP; Schulz S; Zischka H; Rust C
Biochem Biophys Res Commun; 2012 Aug; 424(4):758-64. PubMed ID: 22809502
[TBL] [Abstract][Full Text] [Related]
15. Papaverine inhibits bile acid excretion in isolated perfused rat liver.
Kumai T; Hoshino M; Hayakawa T; Higashi K
Hepatology; 1994 Sep; 20(3):692-9. PubMed ID: 8076926
[TBL] [Abstract][Full Text] [Related]
16. Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture.
Lin Y; Havinga R; Verkade HJ; Moshage H; Slooff MJ; Vonk RJ; Kuipers F
Hepatology; 1996 Feb; 23(2):218-28. PubMed ID: 8591844
[TBL] [Abstract][Full Text] [Related]
17. Tauro alpha-muricholate has a biliary transport maximum (Tm) value equivalent to that for tauroursodeoxycholate and tauro beta-muricholate in the rat.
Kanai S; Kitani K; Ohta M; Sato Y
Life Sci; 1994; 54(7):499-505. PubMed ID: 8309352
[TBL] [Abstract][Full Text] [Related]
18. Influence of Verapamil and Cyclosporin A on bile acid metabolism and transport in rat liver slices.
Barth A; Braun J; Müller D
Exp Toxicol Pathol; 2006 Aug; 58(1):31-7. PubMed ID: 16793245
[TBL] [Abstract][Full Text] [Related]
19. Taurine conjugate of 3 alpha,6 beta,7 beta-trihydroxy-5 beta,22-cholen-24-oic acid (tauro-delta 22-beta-muricholate): the major bile acid in the serum of female rats treated with alpha-naphthylisothiocyanate and its secretion by liver slices.
Thompson MB; Davis DG; Morris RW
J Lipid Res; 1993 Apr; 34(4):553-61. PubMed ID: 8496661
[TBL] [Abstract][Full Text] [Related]
20. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes.
Pandak WM; Hylemon PB; Ren S; Marques D; Gil G; Redford K; Mallonee D; Vlahcevic ZR
Hepatology; 2002 Jun; 35(6):1400-8. PubMed ID: 12029625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
